Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies

International Reviews of Immunology

Volumn 17, Issue 42008, 1998, Pages 1-52

  Chomarat, Pascale ^a   Banchereau, Jacques ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

IL 13 receptor; IL 4 receptor; Interleukin 13; Interleukin 4; T lymphocytes

Indexed keywords

IL13RA1 PROTEIN, HUMAN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN RECEPTOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELLULAR IMMUNITY; COMPARATIVE STUDY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; MODELS, BIOLOGICAL; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION;

EID: 0032442862     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830189809084486     Document Type: Article

References (300)

1. Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., Paul W. E. Identification of a T-cell derived B cell growth factor distinct from interleukin-2. J. Exp. Med. 1982; 155: 914 – 921
2. Isacksson P. C., Pure E., Vitetta S., Krammer P. H. Effect on the isotype switch of murine B cells. J. Exp. Med. 1982; 155: 734 – 748
3. Yokota T., Otsuka T., Mosmann T., Banchereau J., Defrance T., Blanchard D., de Vries J. E., Lee F., Arai K. Isolation and characterization of a human inter-leukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell-stimulatory activities. Proc. Natl. Acad. Sci. USA 1986; 83: 5894 – 5898
4. Brown K. D., Zurawski S. M., Mosmann T. R., Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation process. J. Immunol. 1989; 142: 679 – 687
5. McKenzie A. N.J., Culpepper J. A., de Waal Malefyt R., Brière F., Punnonen J., Aversa G., Sato A., Dang W., Cocks B. G., Menon S., de Vries J. E., Banchereau J., Zurawski G. Interleukin-13, a novel T cell-derived cytokine that regulates human monocyte and B cell function. Proc. Natl. Acad. Sci. USA 1993; 90: 3735 – 3739
6. Minty A., Chalon P., Derocq J. M., Dumont X., Guillemot J. C., Kaghad M., Labit C., Leplatois P., Liauzun P., Miloux B., Minty C., Casellas P., Loison G., Lupker J., Shire D., Ferrara P., Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248 – 250
7. O'Garra A., Spits H. The immunobiology of interleukin 4. Res. Immunol. 1993; 144: 567 – 643
8. Brown M. A., Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 1997; 17: 1 – 32
9. Zurawski G., de Vries J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994; 15: 19 – 26
10. McKenzie A. N.J., Li X., Largaespada D. A., Sato A., Kaneda A., Zurawski S. M., Doyle E. L., Milatovich A., Francke V., Copeland N. G., Jenkins N. A., Zurawski G. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J. Immunol. 1993; 150: 5436 – 5444
11. Zurawski S. M., Vega F., Jr., Huyghe B., Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993; 12: 2663 – 2670
12. Sorg R. V., Enczmann J., Sorg U. R., Schneider E. M., Wernet P. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp. Hematol. 1993; 21: 560 – 563
13. Atamas S. P., Choi J., Yurovsky V. V., White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996; 156: 435 – 441
14. Aversa G., Punnonen J., Cocks B. J., de Waal Malefyt R., Vega F., Zurawski S. M., Zurawski G., de Vries J. E. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 1993; 178: 2213 – 2218
15. Kruse N., Tony H. P., Sebald W. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 1992; 11: 3237 – 3244
16. Windsor W. T., Syto R., Durkin J., Das P., Reichert P., Pramanik B., Tindall S., Le H. V., Labdon J., Nagabhushan T. L., Trotta P. P. Disulfide bond assignment of mammalian cell-derived recombinant human interleukin 4. Biophys. J. 1990; 57: 423
17. Minty A. Interleukin-13. Human Cytokines., Handbook for basic and clinical research, B. B. Aggarwal, J. U. Gutterman. Blackwells. 1996; Vol. 2
18. Walter M. R., Cook W. J., Zhao B. G., Cameron R. P., Ealick S. E., Walter R. L., Reichert P., Nagabhushan T. L., Trotta P. P., Bugg C. E. Crystal structure of recombinant human interleukin-4. J. Biol. Chem. 1992; 267: 20371 – 20376
19. Powers R., Garrett D. S., March C. J., Frieden E. A., Gronenborn A. M., Clore G. M. Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. Science 1992; 256: 1673 – 1677
20. Morgan J. G., Dolganov G. M., Robbins S. E., Hinton L. M., Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res. 1992; 20: 5173 – 5179
21. Smirnov D. V., Smirnova M. G., Korobko V. G., Frolova E. I. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995; 155: 277 – 281
22. Abe E., de Waal Malefyt R., Matsuda I., Arai K., Arai N. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 1992; 89: 2864 – 2868
23. Szabo S. J., Gold J. S., Murphy T. L., Murphy K. M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells. Mol. Cell. Biol. 1993; 13: 4793 – 4805
24. Dolganov G., Bort S., Lovett M., Burr J., Schubert L., Short D., McGurn M., Gibson C., Lewis D. B. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23–31. Blood 1996; 87: 3316 – 3326
25. Wenner C. A., Szabo S. J., Murphy K. M. Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J. Immunol. 1997; 158: 765 – 773
26. Hodge M. R., Ranger A. M., Charles de la Brousse F., Hoey T., Grusby M. J., Glimcher L. H. Hyperproliferation and dysregulation of IL-4 expression in NF- ATp-deficient mice. Immunity 1996; 4: 397 – 405
27. Li-Weber M., Krafft H., Krammer P. H. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 1993; 151: 1371 – 1382
28. Li-Weber M., Salgame P., Hu C., Davydov I. V., Krammer P. H. Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets. J. Immunol. 1997; 158: 1194 – 1200
29. Rooney J. W., Hoey T., Glimcher L. H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995; 2: 473 – 483
30. Song Z., Casolaro V., Chen R., Georas S. N., Monos D., Ono S. J. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J. Immunol. 1996; 156: 424 – 429
31. Li-Weber M., Davydov I. V., Krafft H., Krammer P. H. Role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 1994; 153: 4122 – 4133
32. Cabrillat H., Galizzi J. P., Djossou O., Arai N., Yokota T., Arai K., Banchereau J. High affinity binding of human interleukin 4 to cell lines. Biochem. Biophys. Res. Commun. 1987; 149: 995 – 1001
33. Park L. S., Friend D., Sassenfeld H. M., Urdal D. L. Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 1987; 166: 476 – 488
34. Obiri N. I., Leland P., Murata T., Debinski W., Puri R. K. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 1997; 158: 756 – 764
35. He Y. W., Malek T. R. The IL-2 receptor 7c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J. Immunol 1995; 155: 9 – 12
36. de Waal Malefyt R., Abrams J. S., Zurawski S. M., Lecron J. C., Mohan-Peterson S., Sannjanwala B., Bennett B., Silver J., de Vries J. E., Yssel H. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1, and Th2 T cell clones and EBV-transformed B cells. Int. Immunol. 1995; 7: 1405 – 1416
37. Foxwell B. M.J., Woerly G., Ryffel B. Identification of interleukin-4 receptor-associated proteins and expression of both high and low affinity binding on human lymphoid cells. Eur. J. Immunol. 1989; 19: 1637 – 1641
38. Galizzi J. P., Castle B., Djossou O., Harada N., Cabrillat H., Ait Yahia S., Barrett R., Howard M., Banchereau J. Purification of a 130-kDa T cell glycoprotein that binds human interleukin 4 with high affinity. J. Biol. Chem. 1990; 265: 439 – 444
39. Garrone P., Djossou O., Galizzi J. P., Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur. J. Immunol. 1991; 21: 1365 – 1369
40. Galizzi J. P., Zuber C. E., Harada N., Gorman D. M., Djossou O., Kastelein R., Banchereau J., Howard M., Miyajima A. Molecular cloning of a cDNA encoding the human interleukin-4 receptor. Int. Immunol. 1990; 2: 669 – 675
41. Idzerda R. L., March C. J., Mosley B., Lyman S. D., Vanden Bos T., Gimpel S. D., Din W. S., Grabstein K. H., Widmer M. B., Park L. S., Cosman D., Beckmann M. P. Human Interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 1990; 171: 861 – 873
42. Miyajima A., Kitamura T., Harada N., Yokota T., Arai K. Cytokine receptors and signal transduction. Ann. Rev. Immunol. 1992; 10: 295 – 331
43. Keegan A. D., Nelms K., White M., Wang L. M., Pierce J. H., Paul W. E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994; 76: 811 – 820
44. Noguchi M., Nakamura Y., Russel S. M., Ziegler S. F., Tsang M., Cao X., Leonard W. J. Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science 1993; 262: 1877 – 1880
45. Russel S. M., Keegan A. D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Puri R. K., Paul W. E., Leonard W. J. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 1993; 262: 1880 – 1883
46. Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147 – 157
47. Lin J. X., Migone T. S., Tsang M., Friedmann M., Weatherbee J. A., Zhou L., Yamauchi A., Bloom E. T., Mietz J., John S., Leonard W. J. The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 1995; 2: 331 – 339
48. Zurawski S. M., Chomarat P., Djossou O., Bidaud C., McKenzie A. N.J., Miossec P., Banchereau J., Zurawski G. The primary binding subunit of the human Interleukin-4 receptor is also a component of the Interleukin-13 receptor. J. Biol. Chem. 1995; 270: 13869 – 13878
49. Obiri N. I., Debinski W., Leonard W. J., Puri R. K. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for Interleukins 2, 4, 7, 9 and 15. J. Biol. Chem. 1995; 270: 8797 – 8804
50. Vita N., Lefort S., Laurent P., Caput D., Ferrara P. Characterization and comparison of the Interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 1995; 270: 3512 – 3517
51. Matthews D. J., Clark P. A., Herbert J., Morgan G., Armitage R. J., Kinnon C., Minty A., Grabstein K. H., Caput D., Ferrara P., Callard R. Function of the Interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13 and IL-15. Blood 1995; 85: 38 – 42
52. Smerz-Bertling C., Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 1995; 270: 966 – 970
53. Hilton D. J., Zhang J. G., Metcalf D., Alexander W. S., Nicola N. A., Willson T. A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 1996; 93: 497 – 501
54. Aman M. J., Tayebi N., Obiri N., Puri R. K., Modi W. S., Leonard W. J. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 1996; 271: 29265 – 29270
55. Gauchat J. F., Schlagenhauf E., Feng N. P., Moser R., Yamage M., Jeannnin P., Alouani S., Elson G., Notarangelo L. D., Wells T., Eugster H. P., Bonnefoy J. Y. A novel 4-kb interleukin-13 receptor α raRNA expressed in human B. T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur. J. Immunol. 1997; 27: 971 – 978
56. Bochner B. S., Klunk D. A., Sterbinsky S. A., Coffman R. L., Schleimer R. P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 1995; 154: 799 – 803
57. Schnyder B., Lugli S., Feng N., Etter H., Lutz R. A., Ryffel B., Sugamura K., Wunderli-Allenspach H., Moser R. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 1996; 87: 4286 – 4295
58. Caput D., Laurent P., Kaghad M., Lelias J. M., Lefort S., Vita N., Ferrara P. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 1996; 271: 16921 – 16926
59. Billard C., Caput D., Vita N., Ferrara P., Orrico M., Gaulard P., Boumsell L., Bensussan A., Farcet J. P. Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation. Eur. Cytokine Netw. 1997; 8: 19 – 27
60. Fernandez-Botran R., Vitetta E. S. A soluble, high-affinity, interleukin-4 binding protein is present in the biological fluids of mice. Proc. Natl. Acad. Sci. USA 1990; 87: 4202 – 4206
61. Blum H., Wolf M., Enssle K., Rollinghoff M., Gessner A. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J. Immunol. 1996; 157: 1846 – 1853
62. Fernandez-Botran R., Vitetta E. S. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 1991; 174: 673 – 681
63. Fanslow W. C., Clifford K. N., Park L. S., Rubin A. S., Voice R. F., Beckmann M. P., Widmer M. B. Regulation of alloreactivity in vivo, by IL-4 and the soluble IL-4 receptor. J. Immunol. 1991; 147: 535 – 540
64. Maliszewski C. R., Morrissey P. J., Fanslow W. C., Sato T. A., Willis C., Devison B. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 1992; 143: 434 – 448
65. Sato T. A., Widmer M. B., Finkelman F. D., Madani H., Jacobs C. A., Grabstein K. H., Maliszewski C. R. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 1993; 150: 2717 – 2723
66. Zhang J. G., Hilton D. J., Willson T. A., McFarlane C., Roberts B. A., Moritz R. L., Simpson R. J., Alexander W. S., Metcalf D., Nicola N. A. Identification, purification and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned il-13 receptor and il-4 receptor alpha-chains. J. Biol. Chem. 1997; 272: 9474 – 9480
67. Keegan A. D., Ryan J. J., Paul W. E. IL-4 regulates growth and differentiation by distinct mechanisms. The Immunologist 1996; 4: 194 – 198
68. Kawahara A., Minami Y., Taniguchi T. Evidence for a critical role for the cytoplasmic region of the interleukin-2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling. Mol. Cel. Biol. 1994; 14: 5433 – 5440
69. Izuhara K., Harada N. Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of phosphatidylinositol 3-kinase to the IL-4 receptor in a mouse T cell line, HT2. J. Biol. Chem. 1993; 268: 13097 – 13102
70. Welham M. J., Learmonth L., Bone H., Schrader J. W. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 1995; 270: 12286 – 12296
71. Witthuhn B. A., Silvennoinen O., Miura O., Lai K. S., Cwik C., Liu E. T., Ihle J. N. Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature 1994; 370: 153 – 157
72. Yin T., Tsang M. L.S., Yang Y. C. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Mol. Biol. 1994; 269: 26614 – 26617
73. Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z. J., Oishi I., Silvennnoinnen O., Witthuhn B. A., Ihle J. N., Taniguchi T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266: 1045 – 1047
74. Murata T., Noguchi P. D., Puri R. K. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J. Immunol. 1996; 156: 2972 – 2978
75. Wang H. Y., Zamorano J., Yoerkie J. L., Paul W. E., Keegan A. D. The IL-4- induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK-1 expression in human fibrosarcoma cells. J. Immunol. 1997; 158: 1037 – 1040
76. Keegan A. D., Johnston J. A., Tortolani P. J., McReynolds L. J., Kinzer C., O'Shea J. J., Paul W. E. Similarities and differences in signal transduction by interleukin-4 and interleukin 13: analysis of Janus kinase activation. Proc Natl. Acad. Sci. USA 1995; 92: 7681 – 7685
77. Palmer-Crocker R. L., Hughes C. C., Pober J. S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Invest. 1996; 98: 604 – 609
78. Murata T., Puri R. K. Comparison of IL-13 and IL-4-induced signaling in EBV- immortalized human B cells. Cell. Immunol. 1997; 175: 33 – 40
79. Wang L. M., Keegan A. D., Paul W. E., Heidaran M. A., Gutkind J. S., Pierce J. H. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J. 1992; 11: 4899 – 4908
80. Wang L. M., Michieli P., Lie W. R., Liu F., Lee C. C., Minty A., Sun X. J., Levine A., White M. F., Pierce J. H. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood 1995; 86: 4218 – 4227
81. Koettnitz K., Kalthoff F. S. Human interleukin-4 receptor signalling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 1993; 23: 988 – 991
82. Schnyder B., Lahm H., Woerly G., Odartchenko N., Ryffel B., Car B. D. Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1. Biochem. J. 1996; 315: 767 – 774
83. Harada N., Yang G., Miyajima A., Howard M. Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor. J. Biol. Chem. 1992; 267: 22752 – 22758
84. Musso T., Varesio L., Zhang X., Rowe T. K., Ferrara P., Ortaldo J. R., O'Shea J. J., McVicar D. W. IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J. Exp. Med. 1994; 180: 2383 – 2388
85. Hou J., Schindler U., Henzel W. J., Ho T. C., Brasseur M., McKnight S. L. An interleukin-4-induced transcription factor: IL-4 stat. Science 1994; 265: 1701 – 1706
86. Quelle F. W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S. M., Cleveland J. L., Pierce J. H., Keegan A. D., Nelms K., Paul W. E., Ihle J. N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 1995; 15: 3336 – 3343
87. Schindler U., Wu P., Rothe M., Brasseur M., McKnight S. L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995; 2: 689 – 697
88. Ohmori Y., Smith M. F., Hamilton T. A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 1996; 157: 2058 – 2065
89. Kaplan M. H., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4: 313 – 319
90. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 627 – 630
91. Takeda K., Kamanaka M., Tanaka T., Kishimoto T., Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 1996; 157: 3220 – 3222
92. Shimoda K., van Deursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A., Chu C., Quelle F. W., Nosaka T., Vignali D. A.A., Doherty P. C., Grosveld G., Paul W. E., Ihle J. N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630 – 633
93. Lai S. Y., Molden J., Liu K. D., Puck J. M., White M. D., Goldsmith M. A. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 1996; 15: 4506 – 4514
94. Izuhara K., Heike T., Otsuka T., Yamaoka K., Mayumi M., Imamura T., Niho Y., Harada N. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem. 1996; 271: 619 – 622
95. Kotanides H., Reich N. C. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 1993; 262: 1265 – 1267
96. Kohler I., Alliger P., Minty A., Caput D., Ferrara P., Holl-Neugebauer B., Rank G., Rieber E. P. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL-4 sharing a DNA binding motif with an interferon-gamma-induced nuclear binding factor. FEBS. Lett. 1994; 345: 187 – 192
97. Schindler C., Kashleva H., Pernis A., Pine R., Rothman P. STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J. 1994; 13: 1350 – 1356
98. Izuhara K., Feldman R. A., Greer P., Harada N. Interaction of the c-fes, proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 1994; 269: 18623 – 18629
99. Izuhara K., Feldman R. A., Greer P., Harada N. Interleukin-4 induces association of c-fes, proto-oncogene product with phosphatidylinositol-3 kinase. Blood 1996; 88: 3910 – 3918
100. Finney M., Guy G. R., Michell R. H., Gordon J., Dugas B., Rigley K. P., Callard R. E. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 1990; 20: 151 – 156
101. Sozzani P., Cambon C., Vita N., Seguelas M. H., Caput D., Ferrara P., Pipy B. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol. Chem. 1995; 270: 5084 – 5088
102. Justement L., Chen Z. Z., Harris L. K., Ransom J. T., Sandoval V. S., Smith C., Rennick D., Roehm N., Cambier J. BSF-1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes. J. Immunol. 1986; 137: 3664 – 3670
103. Arruda S., Ho J. L. IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. J. Immunol. 1992; 149: 1258 – 1264
104. Dokter W. H.A., Sierdsema S. J., Esselink M. T., Halie M. R., Vellenga E. Interleukin-4-mediated inhibition of c-fos, mRNA expression: Role of the lipoxygenase directed pathway. Leukemia 1994; 8: 1181 – 1184
105. McGarvie G. M., Cushley W. The effect of recombinant interleukin 4 upon protein kinase activities associated with murine and human B lymphocyte plasma membranes. Cell Signal 1989; 1: 447 – 460
106. Mire-Sluis A. R., Thorpe R. Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa protein. J. Biol. Chem. 1991; 266: 18113 – 18118
107. Jung T., Wijdenes J., Neumann C., de Vries J. E., Yssel H. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 1996; 26: 571 – 577
108. Minty A., Asselin S., Bensussan A., Shire D., Vita N., Vyakarnam A., Wijdenes J., Ferrara P., Caput D. The related cytokines IL-13 and IL-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 1997, In press
109. Mosmann T. R., Coffman R. L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145 – 173
110. Van Der Pouw Kraan T. C., Boeije L. C., Troon J. T., Rutschmann S. K., Wijdenes J., Aarden L. A. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J. Immunol. 1996; 156: 1818 – 1823
111. Alzona M., Jäck H. M., Fisher R. I., Ellis T. M. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 1994; 153: 2861 – 2867
112. Del Prete G., Maggi E., Pizzolo G., Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol. Today 1995; 16: 76 – 80
113. Schandene L., Ferster A., Mascart-Lemone F., Crusiaux A., Gerard C., Marchant A., Lybin M., Velu T., Sariban E., Goldman M. T helper type 2-like cells and therapeutic effects of interferon–gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 1993; 23: 56 – 60
114. Sunder-Plassmann R., Majdiç O., Knapp W., Holler W. High IL-4 production is a stable phenotype of CD8neg CD45R Aneg CD27neg T cells. Cell. Immunol. 1995; 160: 309 – 313
115. Autran B., Legac E., Blanc C., Debré P. A ThO/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J. Immunol. 1995; 154: 1408 – 1417
116. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D. H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 1997; 185: 825 – 831
117. Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R /V2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997; 185: 817 – 824
118. Gajewski T. F., Joyce J., Fitch F. W. Anti-proliferative effect of IFN-γ in immune regulation III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J. Immunol. 1989; 143: 15 – 22
119. Peleman R., Wu J., Fargeas C., Delespesse G. Recombinant interleukin-4 suppresses the production of interferon γ by human mononuclear cells. J. Exp. Med. 1989; 170: 1751 – 1756
120. Coffman R. L., Varkila K., Scott P., Chatelain R. Role of cytokines in the differentiation of CD4+ T cell subsets in vivo. Immunol. Rev. 1991; 123: 189 – 207
121. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFNγ production by T cells. Nature 1995; 378: 88 – 91
122. Coffman R. L., von der Weid T. Multiple pathways for the initiation of T helper 2 (Th2) responses. J. Exp. Med. 1997; 185: 373 – 375
123. Rincon M., Anguita J., Nakamura T., Fikrig E., Flavell R. A. IL-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 1997; 185: 461 – 469
124. Gause W. C., Halvorson M. J., Lu P., Greenwald R., Linsley P., Urban J. F., Finkelman F. D. The function of costimulatory molecules and the development of IL-4 producing T cells. Immunol. Today 1997; 18: 115 – 120
125. Kalinski P., Hilkens C. M.U., Wierenga E. A., Van der Pouw-Kraan T. C.T.M., Van Lier R. A.W., Bos J. D., Kapsenberg M. L., Snijdewint F. G.M. Functional maturation of human naive T helper cells in the absence of accessory cells. J. Immunol. 1995; 154: 3753 – 3760
126. Seder R. A., Le Gros G. G. The functional role of CD8+ T helper type 2 cells. J. Exp. Med. 1995; 181: 5 – 7
127. Erard F., Wild M. T., Garcia-Snaz J. A., Le Gros G. G. Switch of CD8 T cells to noncytolytic CD8- CD4+ cells that make Th2 cytokines and help B cells. Science 1993; 260: 1802 – 1805
128. Sad S., Marcotte R., Mosmann T. R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271 – 279
129. Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279 – 282
130. Paganelli R., Scala E., Ansotegui I. L., Ausiello C. M., Halapi E., Fanales- Belasio E., D'Offizi G., Mezzaroma I., Pandolfi F., Fiorilli M., Cassone A., Aiuti F. CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J. Exp. Med. 1995; 181: 423 – 428
131. Uyemura K., Pirmez C., Sieling P. A., Kiene K., Paes-Oliveira M., Modlin R. L. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor. J. Immunol. 1993; 151: 7095 – 7104
132. Manetti R., Annunziato F., Biagiotti R., Giudizi M. G., Piccinni M. P., Giannarini L., Sampognaro S., Parronchi P., Vinante F., Pizzolo G., Maggi E., Romagnani S. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J. Exp. Med. 1994; 180: 2407 – 2411
133. Yoshimoto T., Paul W. E. CD4pos, NKl.lpos T cells promptly produce interleukin 4 in response to in vivo, challenge with anti-CD3. J. Exp. Med. 1994; 179: 1285 – 1295
134. Bendelac A. Mouse NK1 + T cells. Curr. Opinion. Immunol. 1995; 7: 367 – 374
135. Brunner T., Heusser C. H., Dahinden C. A. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 1993; 177: 605 – 611
136. Li H., Sim T. C., Alam R. IL-13 released by and localized in human basophils. J. Immunol. 1996; 156: 4833 – 4838
137. Brown M. A., Pierce J. H., Watson C. J., Falco J., Ihle J. N., Paul W. E. B cell stimulatory factor-1/inter Ieukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987; 50: 809 – 818
138. Burd P. R., Thompson W. C., Max E. E., Mills F. C. Activated mast cells produce interleukin-13. J. Exp. Med. 1995; 181: 1373 – 1380
139. Bradding P., Feather I. H., Howarth P. H., Mueller R., Roberts J. A., Britten K., Bews J. P.A., Hunt T. G., Okayama Y., Heusser C. H. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992; 176: 1381 – 1386
140. Pawankar R., Okuda M., Yssel H., Okumura K., Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilon Rl, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 1997; 99: 1492 – 1499
141. Moqbel R., Ying S., Barkins J., Newman T. M., Kimmit P., Wakelin M., Taborda-Barata L., Meng Q., Corrigan C. J., Durham S. R., Kay A. B. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 1995; 155: 4939 – 4947
142. Kindler V., Matthes T., Jeannin P., Zubler R. H. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur. J. Immunol. 1995; 25: 1239 – 1243
143. Fior R., Vita N., Raphael M., Minty A., Maillot M. C., Crevon M. C., Caput D., Biberfeld P., Ferrara P., Galanaud P., Emilie D. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur. Cytokine Netw. 1994; 5: 593 – 600
144. Defrance T., Aubry J. P., Rousset F., Vanbervliet B., Bonnefoy J. Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K., De Vries J., Banchereau J. Human recombinant interleukin 4 induces Fee receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 1987; 165: 1459 – 1467
145. Punnonen J., Aversa G., Cocks B. G., McKenzie A. N.J., Menon S., Zurawski G., de Waal Malefyt R., de Vries J. E. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993; 90: 3730 – 3734
146. Chaouchi N., Wallon C., Goujard C., Tertian G., Rudent A., Caput D., Ferrera P., Minty A., Vazquez A., Delfraissy J. F. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro, apoptosis. Blood 1996; 87: 1022 – 1029
147. Shields J. G., Armitage R., Jamieson B. N., Beverley P. C.L., Callard R. E. Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunol. 1989; 66: 224 – 227
148. Vallé A., Aubry J. P., Durand I., Banchereau J. IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions. Int. Immunol. 1991; 3: 229 – 235
149. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J. P., van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its Ligand. Ann. Rev. Immunol. 1994; 12: 881 – 922
150. Van Kooten C., Banchereau J. CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv. Immunol. 1995; 61: 1 – 77
151. Smeland E. B., Blomhoff H. K., Funderud S., Shalaby M. R., Espevik T. Interleukin 4 induces selective production of Interleukin 6 from normal human B lymphocytes. J. Exp. Med. 1989; 170: 1463 – 1468
152. Defrance T., Vanbervliet B., Aubry J. P., Takebe Y., Arai N., Miyajima A., Yokota T., Lee T., Arai K., de Vries J. E., Banchereau J. B cell growth-promoting activity of recombinant human interleukin-4. J. Immunol. 1987; 139: 1135 – 1141
153. Cocks B. C., de Waal Malefyt R., Galizzi J. P., de Vries J. E., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 1993; 5: 657 – 663
154. Banchereau J., de Paoli P., Valle A., Garcia E., Rousset F. Long term human B cell lines dependent on interleukin 4 and antibody to CD40. Science 1991; 251: 70 – 72
155. Defrance T., Vanbervliet B., Aubry J. P., Banchereau J. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 1988; 168: 1321 – 1337
156. Defrance T., Carayon P., Billian G., Guillemot J. C., Minty A., Caput D., Ferrara P. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 1994; 179: 135 – 143
157. Karray S., Dautry-Varsat A., Tsudo M., Merle-Beral H., Debré P., Galanaud P. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J. Immunol. 1990; 145: 1152 – 1158
158. Fluckiger A. C., Briere F., Zurawski G., Bridon J. M., Banchereau J. IL-13 has only a subset of IL-4 like activities on B chronic lymphocytic leukemia cells. Immunology 1994; 83: 397 – 403
159. Coffman R. L., Ohara J., Bond M. W., Carty J., Zlotnick A., Paul W. E. B cell stimulatory factor-1 enhances the lgE response of lipopolysaccharide-activated B cells. J. Immunol. 1986; 136: 4538 – 4541
160. Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 1991; 173: 705 – 710
161. Punnonen J., Cocks B. G., de Vries J. E. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J. Immunol. 1995; 155: 4248 – 42254
162. Ezernieks J., Schnarr B., Metz K., Duschl A. The human lgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-alpha and interferon-gamma via an interferon-gamma-activated site and its flanking regions. Eur. J. Biochem. 1996; 240: 667 – 673
163. Jabara H. H., Loh R., Ramesh K., Vercelli D., Geha R. S. Sequential switching from u to epsilon via gamma4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 1993; 151: 4528
164. Shapira S. K., Vercelli D., Jabara H. H., Fu S. M., Geha R. S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 1992; 175: 289 – 292
165. Gascan H., Gauchat J. F., Roncarolo M. G., Yssel H., Spits H., de Vries J. E. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J. Exp. Med. 1991; 173: 747 – 750
166. Kühn R., Rajewsky K., Müller W. Generation and analysis of interleukin-4 deficient mice. Science 1991; 254: 707 – 710
167. Tepper R. I., Levinson D. A., Stanger B. Z., Campos-Torres J., Abbas A. K., Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990; 62: 457 – 467
168. Carballido J. M., Schols D., Namikawa R., Zurawski S., Zurawski G., Roncarolo M. G., de Vries J. E. IL-4 induces human B cell maturation and lgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo, treatment with an IL-4/IL-13 receptor antagonist. J. Immunol. 1995; 155: 4162 – 4170
169. Mosmann T. R., Bond M. W., Coffman R. L., Ohara J., Paul W. E. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 1986; 83: 5654 – 5658
170. Hu-Li J., Shevach E. M., Mizuguchi J., Ohara J., Mosmann T., Paul W. E. B cell stimulatory factor 1/interleukin 4 is a potent costimulant for normal resting T lymphocytes. J. Exp. Med. 1987; 165: 157 – 172
171. Harel-Bellan A., Durum S., Muegge K., Abbas A. K., Farrar W. L. Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones. J. Exp. Med. 1988; 168: 2309 – 2318
172. Gaya A., Alsinet E., Martorell J., Places L., De La Calle O., Yagüe J., Vives J. Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset. Int. Immunol. 1990; 2: 685 – 689
173. Spits H., Yssel H., Paliard X., Kastelein R., Figdor D., de Vries J. E. Interleukin-4 inhibits interleukin-2 mediated induction of human lymphokine activated killer cells, but not the generation of antigen specific cytotoxic T lymphocytes in mixed leucocyte cultures. J. Immunol. 1988; 141: 29 – 36
174. Horohov D. W., Crim J. A., Smith P. L., Siegel J. P. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J. Immunol. 1988; 141: 4217 – 4223
175. Kawakami Y., Custer M. C., Rosenberg S. A., Lotze M. T. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol. 1989; 142: 3452 – 3461
176. Warren H. S., Kinnear B. F., Phillips J. H., Lanier L. L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 1995; 154: 5144 – 5152
177. Banchereau J., Sealand S. Interleukin-4. Growth factors and cytokines in health and disease. 1997; 2A: 85 – 142
178. Vellenga E., Dokter W., Halie R. M. Interleukin-4 and its receptor; Modulating effects on immature and mature hematopoietic cells. Leukemia 1993; 7: 1131 – 1141
179. Sonoda Y., Kuzuyama Y., Tanaka S., Yokota S., Maekawa T., Clark S. C., Abe T. Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood 1993; 81: 624 – 630
180. Xi X., Schlegel N., Caen J. P., Minty A., Fournier S., Caput D., Ferrera P., Han Z. C. Differential effects of recombinant human interleukin-13 on the in vitro, growth of human haemopoietic progenitor cells. Br. J. Haematol. 1995; 90: 921 – 927
181. Lai Y. H., Heslan J. M., Poppema S., Elliot J. F., Mosmann T. R. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 1996; 156: 3166 – 3173
182. Sakamoto O., Hashiyama M., Minty A., Ando M., Suda T. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 1995; 85: 3487 – 3493
183. Jacobsen S. E., Okkenhaug C., Veiby O. P., Caput D., Ferrara P., Minty A. Interleukin-13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 1994; 180: 75 – 82
184. de Waal Malefyt R., Figdor C., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J. E. Effects of IL-13 on pheno-type, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by 1FNγ or IL-10. J. Immunol. 1993; 151: 6370 – 6381
185. Te Velde A. A., Rousset F., Péronne C., de Vries J. E., Figdor C. IL-4 induced expression of Fc, RIIb and soluble Fc, RIIb release from human monocytes is downregulated by IFNα and IFNγ. J. Immunol. 1990; 144: 3052 – 3059
186. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinman R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83 – 93
187. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994; 179: 1109 – 1118
188. Piemonti L., Bernasconi S., Luini W., Trobonjaca Z., Minty A., Allavena P., Mantovani A. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Netw. 1995; 6: 245 – 252
189. Zhou L. J., Tedder T. F. CD 14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 1996; 93: 2588 – 2592
190. Pickl W. F., Majdic O., Kohl P., Stockl J., Riedl E., Scheinecker C., Bello-Fernandez C., Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 1996; 157: 3850 – 3859
191. Defife K. M., Jenney C. R., McNally A. K., Colton E., Anderson J. M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 1997; 158: 3385 – 3390
192. Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential anti-inflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 1989; 86: 3803 – 3807
193. D'Andrea A., Ma X., Aste-Amezaga M., Paganin C., Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 1995; 181: 537 – 546
194. Vannier E., de Waal Malefyt R., Salazar-Montes A., de Vries J. E., Dinarello C. A. Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. Blood 1996; 87: 3307 – 3315
195. Kambayashi T., Jacob C. O., Strassmann G. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 1996; 171: 153 – 158
196. Sebire G., Delfraissy J. F., Demotes-Mainard J., Oteifeh A., Emilie D., Tardieu M. Interleukin-13 and interleukin-4 act as inducers in human microglial cells. Cytokine 1996; 8: 636 – 641
197. Corcoran M. L., Stetler-Stevenson W. G., Brown P. D., Wahl L. M. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 1992; 267: 515 – 519
198. Abramson S. L., Gallin J. I. IL-4 inhibits superoxide production by human mononuclear phagocytes. J. Immunol. 1990; 144: 625 – 63
199. Endo T., Ogushi F., Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma. J. Immunol. 1996; 156: 2240 – 2246
200. Yano S., Sone S., Nishioka Y., Mukaida N., Matsushima K., Ogura T. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemoractic and activating factor. J. Leukoc. Biol. 1995; 57: 303 – 309
201. Weiss G., Bodgan C., Hentze M. W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 1997; 158: 420 – 425
202. Deng W., Ohmori Y., Hamilton T. A. Mechanisms of IL-4-mediated suppression of IP-gene expression in murine macrophages. J. Immunol. 1994; 153: 2130 – 2136
203. Vasse M., Paysant I., Soria J., Mirshahi S. S., Vannier J. P., Soria C. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br. J. Haematol. 1996; 93: 955 – 9961
204. Gautam S. C., Chikkala N. F., Hamilton T. A. Anti-inflammatory action of IL-4. J. Immunol. 1992; 148: 1411 – 1415
205. Muchamuel T., Menon S., Pisacane P., Howard M. C., Cockayne D. A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. J. Immunol. 1997; 158: 2898 – 2903
206. Riemann D., Kehlen A., Langner J. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin. Exp. Immunol. 1995; 100: 277 – 283
207. Van Hal P. T.W., Hopstaken-Broos J. P.M., Prins A., Favaloro E. J., Huijbens R. J.F., Hilvering C., Figdor C. G., Hoogsteden H. C. Potential indirect antiinflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2). J. Immunol. 1994; 153: 2718 – 2728
208. Nassar G. M., Morrow J. D., Roberts L. J., Lakkis F. G., Badr K. F. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 1994; 269: 27631 – 27634
209. Lehn M., Weiser W. Y., Engelhorn S., Gillis S., Remold H. G. IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J. Immunol. 1989; 143: 3020 – 3024
210. Kumaratilake L. M., Ferrante A. IL-4 inhibits macrophage-mediated killing of Plasmodium Falciparum in vitro. J. Immunol. 1992; 149: 194 – 199
211. Montanier L. J., Doyle A. G., Collin M., Herbein G., Illei P., James W., Minty A., Caput D., Ferrara P., Gordon S. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. 1993; 178: 743 – 747
212. Mikovits J. A., Meyers A. M., Ortaldo J. R., Minty A., Caput D., Ferrara P., Ruscetti F. W. IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes. J. Leukoc. Biol. 1994; 56: 340 – 346
213. Baskar P., Silberstein D. S., Pincus S. H. Inhibition of IgG-triggered human eosinophil function by IL-4. J. Immunol. 1990; 144: 2321 – 2326
214. Luttmann W., Knoechel B., Foerster M., Matthys H., Virchow J. C., Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol. 1996; 157: 1678 – 1683
215. Bober L. A., Waters T. A., Pugliese-Sivo C. C., Sullivan L. M., Narula S. K., Grace M. J. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin. Exp. Immunol. 1995; 99: 129 – 136
216. Wertheim W. A., Kunkel S. L., Standiford T. J., Burdick M. D., Becker F. S., Wilke C. A., Gilbert A. R., Strieter R. M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 1993; 151: 2166 – 2175
217. Girard D., Paquin R., Naccache P. H., Beaulieu A. D. Effects on interleukin-13 on human neutrophil functions. J. Leukoc. Biol. 1996; 59: 412 – 419
218. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J. G., Dower S. K., Sims J. E., Mantovani A. Interleukin-1 Type II receptor: as a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472 – 475
219. Colotta F., Re F., Muzio M., Polentarutti N., Minty A., Caput D., Ferrara P., Mantovani A. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol Chem. 1994; 269: 12403 – 12406
220. Nilsson G., Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur. J. Immunol. 1995; 25: 870 – 873
221. Postlethwaite A. E., Seyer J. M. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70–88 and 89–122. J. Clin. Invest. 1991; 87: 2147 – 2152
222. Gillery P., Fertin C., Nicolas J. F., Chastang F., Kalis B., Banchereau J., Maquart F. X. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. FEBS Lett. 1992; 302: 231 – 234
223. Postlethwaite A. E., Holness M. A., Katai H., Raghow R. Human fibroblasts synthetize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 1992; 90: 1479 – 1485
224. Wegrowski Y., Paltot V., Gillery P., Kalis B., Randoux A., Maquart F. X. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem. J. 1995; 307: 673 – 678
225. Katz Y., Stav D., Barr J., Passwell J. H. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumor necrosis factor (TNF)-stimulated fibroblasts. Clin. Exp. Immunol. 1995; 101: 150 – 156
226. Dechanet J., Briolay J., Rissoan M. C., Chomarat P., Galizzi J. P., Banchereau J., Miossec P. Interleukin 4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 1993; 151: 4908 – 4917
227. Dechanet J., Taupin J. L., Chomarat P., Rissoan M. C., Moreau J. F., Banchereau J., Miossec P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 1994; 24: 3222 – 3228
228. Schlaak J. F., Schwarting A., Knolle P., Meyer zum Buschenfelde K. H., Mayet W. Effects of Th1 and Th2 cytokines on cytokine production and 1CAM-1 expression on synovial fibroblasts. Ann. Rheum. Dis. 1995; 54: 560 – 565
229. Tushinski R. J., Larsen A., Park L. S., Spoor E. Interleukin 4 alone or in combination with interleukin 1 stimulates 3T3 fibroblasts to produce colony-stimulating factors. Exp. Hematol. 1991; 19: 238 – 244
230. Seitz M., Loetscher P., Dewald B., Towbin H., Baggiolini M. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur. J. Immunol. 1996; 26: 2198 – 2202
231. Piela-Smith T. H., Broketa G., Hand A., Korn J. H. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J. Immunol. 1992; 148: 1375 – 1381
232. Toi M., Bicknell R., Harris A. L. Inhibition of colon and breast carcinoma cell growth by Interleukin-4. Cancer Res. 1992; 52: 275 – 279
233. Thornhill M. H., Wellicome S. M., Mahiouz D. L., Lanchbury J. S.S., Kyan-Aung U., Haskard D. O. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and-independent binding mechanisms. J. Immunol. 1991; 146: 592 – 598
234. Palmer-Crocker R. L., Pober J. S. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J. Immunol. 1995; 154: 2838 – 2845
235. Lugli S. M., Feng N., Heim M. H., Adam M., Schnyder B., Etter H., Yamage M., Eugster H. P., Lutz R. A., Zurawski G., Moser R. Tumor necrosis factor α enhances the expression of the interleukin (IL)-4 receptor α-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation. J. Biol Chem. 1997; 272: 5487 – 5494
236. Moser R., Fehr J., Bruijnzeel P. L.B. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 1992; 149: 1432 – 1438
237. Valent P., Bevec D., Maurer D., Besemer J., Di Padova F., Butterfield J. H., Speiser W., Majdic O., Lechner K., Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Immunol. 1991; 88: 3339 – 3342
238. Thornhill M. H., Kaskard D. O. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J. Immunol. 1990; 145: 865 – 872
239. Kotowicz K., Callard R. E., Friedrich K., Matthews D. J., Klein N. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int. Immunol. 1996; 8: 1915 – 1925
240. Klein N. J., Rigley K. P., Callard R. E. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. Int. Immunol. 1993; 5: 293 – 301
241. Iademarco M. F., Barks J. L., Dean D. C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 1995; 95: 264 – 271
242. Briscoe D. M., Cotran R. S., Pober J. S. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo., Correlation with CD3+ T cell infiltration. J. Immunol. 1992; 149: 2954 – 2960
243. Sironi M., Sciacca F. L., Matteuci C., Conni M., Vecchi A., Bernasconi S., Minty A., Caput D., Ferrara P., Colotta F., Mantovani A. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994; 84: 1913 – 1921
244. Howells G., Pham P., Taylor D., Foxwell B., Feldman M. Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-γ. Eur. J. Immunol. 1991; 21: 97 – 101
245. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 1995; 154: 1870 – 1878
246. Herbert J. M., Savi P., Laplace M. C., Lale A., Dol F., Dumas A., Labit C., Minty A. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett. 1993; 328: 268 – 270
247. Rousselet G., Busson P., Billaud M., Guillon J. M., Scamps C., Wakasugi H., Lenoir G., Tursz T. Structure and regulation of the Blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma. Int. Immunol. 1990; 2: 1159 – 1166
248. Phillips J. O., Everson M. P., Moldoveanu Z., Lue C., Mestecky J. Synergistic effect of IL-4 and IFN-γ on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J. Immunol. 1990; 145: 1740 – 1744
249. Galy A. H., Spits H. IL-1, IL-4, and IFN-γ differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. J. Immunol. 1991; 147: 3823 – 3830
250. Kolios G., Robertson D. A., Jordan N. J., Minty A., Caput D., Ferrara P., Westwick J. Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br. J. Immunol. 1996; 119: 351 – 359
251. Berkman N. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human epithelial cells. Immunology 1996; 89: 363 – 367
252. Berkman N., Robichaud A., Krishnan V. L., Roesems G., Robbins R., Jose P. J., Barnes P. J., Chung K. F. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10,-13. Immunology 1996; 87: 599 – 603
253. Zund G., Madara J. L., Dzus A. L., Awtrey C. S., Colgan S. P. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J. Biol. Chem. 1996; 271: 7460 – 7464
254. Loyer P., Ilyin G., Razzak Z. A., Dézier J. F., Banchereau J., Campion J. P., Guguen-Guillouzo C., Guillouzo A. IL-4 modulates production of acute phase proteins in adult human hepatocytes. FEBS Lett. 1993; 336: 215 – 220
255. Grunfeld C., Soued M., Adi S., Moser A. H., Fiers W., Dinarello C. A., Feingold K. R. Interleukin-4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin-1 and interleukin-6 but not interferon-α. Cancer Res. 1991; 51: 2803 – 2807
256. Razzak Z. A., Loyer P., Fautrel A., Gautier J. C., Corcos L., Turlin B., Beaune P., Guillouzo A. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 1993; 44: 707 – 715
257. Parronchi P., De Carli M., Manetti R., Simonelli C., Piccini M. P., Macchia D., Maggi E., Del Prete G., Ricci M., Romagnani S. Aberrant interleukin (IL)4 and IL5 production in vitro, by CD4+ helper T cells from atopic subjects. Eur. J. Immunol. 1992; 87: 58 – 69
258. Lester M. R., Hofer M. F., Gately M., Trumble A., Leung D. Y.M. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J. Immunol. 1995; 154: 6174 – 6181
259. Rousset F., Robert J., Andary M., Bonnin J. P., Souillet G., Chretien I., Briere F., Pene J., de Vries J. E. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 1991; 87: 58 – 69
260. Jutel M., Pichler W. J., Skrbic D., Urwyler A., Dahinden C., Müller U. R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 1995; 154: 4187 – 4194
261. Secrist H., Chelen C. J., Wen Y., Marshall J. D., Umetsu D. T. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 1993; 178: 2123 – 2130
262. Vollenweider S., Saurat J. H., Rocken M., Hauser C. Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro, IgE synthesis in patients with atopic dermatitis. J. Allergy Clin. Immunol. 1991; 87: 1088 – 1095
263. Levy F., Kristofic C., Heusser C., Brinkmann V. Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int. Arch. Allergy. Immunol. 1997; 112: 49 – 58
264. Reddy M. M., Weissman A. M., Mazza D. S., Meriney D. K., Johns M., Carrabis S., Grieco M. H. Circulating elevated levels of soluble CD23, interleukin 4, and CD20+ CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann. Allergy 1992; 69: 131 – 134
265. Kapsenberg M. L., Wierenga E. A., Van Der Heijden F. L., Bos J. D. Atopic dermatitis and CD4+ atopen-specific Th2 lymphocytes. Eur. J. Dermatol. 1992; 8: 601 – 607
266. Parronchi P., Macchia D., Piccini M. P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A. A., Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 1991; 88: 4538 – 4542
267. Secrist H., DeKruyff R. H., Umetsur D. T. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 1995; 181: 1081 – 1089
268. Marsh D. G., Neely J. D., Breazeale D. R., Ghosh B., Freidhoff L. R., Ehrlich-Kautzky E., Schou C., Krishnaswamy G., Beaty T. H. Linkage analysis of 1L4 and other chromosome 5q31–1 markers and total serum immunoglobulin E concentrations. Science 1994; 264: 1152 – 1156
269. Tepper R. I., Pattengale P. K., Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989; 57: 503 – 512
270. Tepper R. I., Coffman R. L., Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548 – 551
271. Bosco M. C., Giovarelli M., Forni M., Modesti A., Scarpa G., Masuelli L., Forni G. Low doses of interleukin 4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J. Immunol. 1990; 145: 3136 – 3143
272. Golumbek P. T., Lazenby A. J., Levitsky H. I., Jaffee L. M., Karasuyama H., Baker M., Pardoll D. M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 1991; 254: 713 – 716
273. Lebel-Binay S., Laguerre B., Quintin-Colonna F., Conjeaud H., Magazin M., Miloux B., Pecceu F., Caput D., Ferrara P., Fradelizi D. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13. Eur. J. Immunol. 1995; 25: 2340 – 2348
274. Pandrau D., Saeland S., Duvert V., Durand I., Manel A. M., Zabot M X, Philippe N., Banchereau J. Interleukin-4 inhibits in vitro, proliferation of leukemic and normal human B cell precursors. J. Clin. Invest. 1992; 90: 1697 – 1706
275. Akashi K., Shibuya T., Harada M., Takamatsu Y., Uike N., Eto T., Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J. Clin. Invest. 1991; 88: 223 – 230
276. Obiri N. I., Hillman G. G., Haas G. P., Sud S., Puri R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro, by interleukin-4. J. Clin. Invest. 1993; 91: 88 – 93
277. Renard N., Duvert V., Banchereau J., Saeland S. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 1994; 84: 2253 – 2260
278. Bruserud O. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts. Leukemia 1996; 10: 1497 – 1503
279. Topp M. S., Koenigsmann M., Mire-Sluis A., Oberberg D., Eitelbach F., Von Marschall Z., Notter M., Reufi B., Stein H., Thiel E., Berdel W. E. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro, and in vivo. Blood 1993; 82: 2837 – 2844
280. Topp M. S., Papadimitriou C. A., Eitelbach F., Koenigsmann M., Oelmann E., Koehler B., Oberberg D., Reufi B., Stein H., Thiel E., et al. Recombinant human interleukin-4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 1995; 55: 2173 – 2176
281. Serve H., Oelmann E., Herweg A., Oberberg D., Serve S., Reufi B., Mucke C., Minty A., Thiel E., Berdel W. E. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res. 1996; 56: 3583 – 3588
282. Puri R. K., Leland P., Obiri N. I., Husain S. R., Kreitman R. J., Haas G. P., Pastan I., Debinski W. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 1996; 87: 4333 – 4339
283. Hurford R. K., Dranoff G., Mulligan R. C., Tepper R. I. Gene therapy of metastatic cancer by in vivo, retroviral gene targeting. Nature Genetics 1995; 10: 430 – 435
284. Miossec P., Briolay J., Dechanet J., Wijdenes J., Martinez-Valdez H., Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo, model of rheumatoid synovitis. Arthritis Rheum. 1992; 35: 874 – 883
285. Hart P. H., Ahernn M. J., Smith M. D., Finlay-Jones J. J. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 1995; 99: 331 – 337
286. Chomarat P., Banchereau J., Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum. 1995; 38: 1046 – 1054
287. Kucharzik T., Lügering N., Weigelt H., Adolf M., Domschke W., Stoll R. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin. Exp. Immunol. 1996; 104: 483 – 490
288. Isomaki P., Luukkainen R., Toivanen P., Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1996; 39: 1693 – 1702
289. Miossec P., Chomarat P., Dechanet J., Moreau J. F., Roux J. P., Delmas P., Banchereau J. Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo, model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 1994; 37: 1715 – 1722
290. Lacey D. L., Erdmann J. M., Teitelbaum S. L., Tan H. L., Ohara J., Shioi A. Interleukin-4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995; 136: 2367 – 2376
291. Onoe Y., Miyaura C., Kaminakayashiki T., Nagai Y., Noguchi K., Chen Q. R., Seo H., Ohta H., Nozawa S., Kudo I., Suda T. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J. Immunol. 1996; 156: 758 – 764
292. Lind M., Deleuran B., Yssel H., Fink-Eriksen E., Thestrup-Pedersen K. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 1995; 7: 78 – 82
293. Racke M. K., Burnett D., Pak S. H., Albert P. S., Cannella B., Raine C. S., McFarlin D. E., Scott D. E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 1995; 154: 450 – 458
294. Shaw M. K., Lorens J. B., Dhawan A., DalCanto R., Tse H. Y., Tran A. B., Bonpane C., Eswaran S. L., Brocke S., Sarvetnick N., Steinman L., Nolan G. P., Fathman C. G. Local delivery of interleukin-4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 1997; 185: 1711 – 1714
295. Cash E., Minty A., Ferrara P., Caput D., Fradelizi D., Rott O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994; 153: 4258 – 4267
296. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185 – 1188
297. Allen J. B., Wong H. L., Costa G. L., Bienkowski M. J., Wahl S. M. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 1993; 151: 4344 – 4351
298. Bessis N., Boissier M. C., Ferrara P., Blankenstein T., Fradelizi D., Fournier C. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 1996; 26: 2399 – 2403
299. Mulligan M. S., Jones M. L., Vaporciyan A. A., Howard M. C., Ward P. A. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 1993; 151: 5666 – 5674
300. Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., Cyopick P., Dnaska J. S., Deloviqtch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87 – 99